TGFB2 and autoimmune uveitis: The protective role of TGF-β2 in ocular immune privilege is further demonstrated in experimental models where the administration of recombinant TGF-β2 can prevent or reduce the severity of autoimmune uveitis by enhancing the population of Tregs in the affected tissues [38].